Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Illumina gets funds for bead-based proteomic arrays:

This article was originally published in Clinica

Executive Summary

Illumina has received a $1.2m grant from the US National Institutes of Health to continue its development of high-multiplex, low-cost arrays to profile protein activity in small volumes of cells or biological fluids. Identifying protein profiles will be valuable in a range of markets including diagnostics, said the San Diego, California firm. By profiling and understanding protein activity, pharmaceutical and biotech firms can identify more targeted drug compounds and discover relevant biomarkers for use in diagnostic products. The company added that its proprietary BeadArray technology provided the throughput, cost-effectiveness and flexibility needed to enable researchers to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel